TARA icon

Protara Therapeutics
TARA

Overview Fund Activity

30 hedge funds and large institutions have $8.17M invested in Protara Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
6
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$3K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$212K
2
Citadel Advisors
2
Citadel Advisors
Florida
$71.1K
3
LPL Financial
3
LPL Financial
California
$22.5K
4
UBS Group
4
UBS Group
Switzerland
$1.72K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$1K

Top Sellers

1
O
1
OrbiMed
New York
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$0
4
Millennium Management
4
Millennium Management
New York
$21.5K
5
Northern Trust
5
Northern Trust
Illinois
$34K
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1K +$313 +228 +46%
Osaic Holdings
27
Osaic Holdings
Arizona
$188 – – –
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$30 +$9 +5 +45%
Bank of America
29
Bank of America
North Carolina
$11 +$11 +6 New
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$4 – – –
O
31
OrbiMed
New York
– -$1.29M -772,584 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
– -$58.4K -34,971 Closed
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
– -$23.1K -13,821 Closed
1
2